Vault-13

RTW INVESTMENTS, LP

NEW YORK, NY · CIK 1493215 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2013 · limited partnership

$11.7bn reported value +16.5% vs Q1 2026
84positions
47.7%in top 10
9 new 26 added 8 reduced 13 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 1,993,687 $1.1bn9.14% 9.14% UnchangedShares held: Q3 2025 2.0m, Q4 2025 2.0m, Q1 2026 2.0m, Q2 2026 2.0m
2 ARGENX SE SPONSORED ADR ARGX ARGX 709,446 $658.2m5.62% 5.62% UnchangedShares held: Q3 2025 673.5k, Q4 2025 673.5k, Q1 2026 709.4k, Q2 2026 709.4k
3 PTC THERAPEUTICS INC COM PTCT PTCT 7,746,415 $631.9m5.39% 5.39% UnchangedShares held: Q3 2025 7.7m, Q4 2025 7.7m, Q1 2026 7.7m, Q2 2026 7.7m
4 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 5,061,175 $620.4m5.30% 5.30% AddedShares held: Q3 2025 5.8m, Q4 2025 5.1m, Q1 2026 5.1m, Q2 2026 5.1m +2.1k +2,122 0.0%
5 CG ONCOLOGY INC COM CGON CGON 8,514,590 $605.0m5.16% 5.16% AddedShares held: Q3 2025 1.7m, Q4 2025 2.0m, Q1 2026 7.0m, Q2 2026 8.5m +1.5m +1,529,782 21.9%
6 INSMED INC COM PAR $.01 INSM INSM 4,842,880 $516.3m4.41% 4.41% UnchangedShares held: Q3 2025 3.1m, Q4 2025 4.8m, Q1 2026 4.8m, Q2 2026 4.8m
7 TANGO THERAPEUTICS INC COM TNGX TNGX 13,900,620 $434.5m3.71% 3.71% AddedShares held: Q3 2025 0, Q4 2025 1.5m, Q1 2026 13.3m, Q2 2026 13.9m +600.0k +600,000 4.5%
8 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 4,251,996 $377.5m3.22% 3.22% AddedShares held: Q3 2025 3.6m, Q4 2025 4.2m, Q1 2026 4.2m, Q2 2026 4.3m +80.0k +80,000 1.9%
9 CELCUITY INC COM CELC CELC 3,304,903 $345.8m2.95% 2.95% AddedShares held: Q3 2025 0, Q4 2025 550.2k, Q1 2026 3.0m, Q2 2026 3.3m +265.3k +265,282 8.7%
10 ERASCA INC COM ERAS ERAS 17,946,754 $328.8m2.81% 2.81% AddedShares held: Q3 2025 0, Q4 2025 146.7k, Q1 2026 16.2m, Q2 2026 17.9m +1.8m +1,789,579 11.1%
11 RADNET INC COM RDNT RDNT 4,846,958 $298.9m2.55% 2.55% AddedShares held: Q3 2025 2.8m, Q4 2025 3.9m, Q1 2026 4.3m, Q2 2026 4.8m +562.0k +561,958 13.1%
12 ORUKA THERAPEUTICS INC COM ORKA ORKA 3,139,030 $298.7m2.55% 2.55% AddedShares held: Q3 2025 1.9m, Q4 2025 2.1m, Q1 2026 2.1m, Q2 2026 3.1m +1.1m +1,080,882 52.5%
13 NATERA INC COM NTRA NTRA 1,000,000 $271.4m2.32% 2.32% ReducedShares held: Q3 2025 2.0m, Q4 2025 1.5m, Q1 2026 1.2m, Q2 2026 1.0m -250.0k -250,000 -20.0%
14 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 7,796,895 $260.3m2.22% 2.22% AddedShares held: Q3 2025 3.3m, Q4 2025 3.0m, Q1 2026 3.6m, Q2 2026 7.8m +4.1m +4,148,100 113.7%
15 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 2,182,631 $259.6m2.22% 2.22% AddedShares held: Q3 2025 0, Q4 2025 1.2m, Q1 2026 1.7m, Q2 2026 2.2m +514.1k +514,131 30.8%
16 CYTOKINETICS INC COM NEW CYTK CYTK 2,862,003 $243.8m2.08% 2.08% AddedShares held: Q3 2025 2.7m, Q4 2025 2.7m, Q1 2026 2.7m, Q2 2026 2.9m +140.8k +140,845 5.2%
17 KAILERA THERAPEUTICS INC COMMON STOCK KLRA KLRA 10,776,820 $237.4m2.03% 2.03% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 10.8m
18 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 2,655,695 $227.9m1.95% 1.95% UnchangedShares held: Q3 2025 2.6m, Q4 2025 2.6m, Q1 2026 2.7m, Q2 2026 2.7m
19 GUARDANT HEALTH INC COM GH GH 1,481,033 $222.2m1.90% 1.90% UnchangedShares held: Q3 2025 1.5m, Q4 2025 1.5m, Q1 2026 1.5m, Q2 2026 1.5m
20 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 1,267,925 $213.7m1.82% 1.82% AddedShares held: Q3 2025 1.1m, Q4 2025 1.1m, Q1 2026 1.1m, Q2 2026 1.3m +205.9k +205,853 19.4%
21 TARSUS PHARMACEUTICALS INC COM TARS TARS 3,357,059 $211.3m1.80% 1.80% AddedShares held: Q3 2025 3.2m, Q4 2025 3.3m, Q1 2026 3.3m, Q2 2026 3.4m +11.0k +11,034 0.3%
22 STOKE THERAPEUTICS INC COM STOK STOK 5,623,525 $184.0m1.57% 1.57% UnchangedShares held: Q3 2025 5.1m, Q4 2025 5.5m, Q1 2026 5.6m, Q2 2026 5.6m
23 UNIQURE NV SHS QURE QURE 3,941,572 $181.5m1.55% 1.55% AddedShares held: Q3 2025 4.4m, Q4 2025 3.7m, Q1 2026 2.6m, Q2 2026 3.9m +1.4m +1,355,216 52.4%
24 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 7,144,524 $180.8m1.54% 1.54% UnchangedShares held: Q3 2025 7.1m, Q4 2025 7.1m, Q1 2026 7.1m, Q2 2026 7.1m
25 REPLIGEN CORP COM RGEN RGEN 1,240,637 $169.3m1.45% 1.45% AddedShares held: Q3 2025 0, Q4 2025 1.1m, Q1 2026 1.2m, Q2 2026 1.2m +34.6k +34,637 2.9%
26 UROGEN PHARMA LTD COM URGN URGN 4,543,895 $167.2m1.43% 1.43% UnchangedShares held: Q3 2025 4.5m, Q4 2025 4.5m, Q1 2026 4.5m, Q2 2026 4.5m
27 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 5,933,815 $159.5m1.36% 1.36% UnchangedShares held: Q3 2025 5.6m, Q4 2025 5.9m, Q1 2026 5.9m, Q2 2026 5.9m
28 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 4,869,798 $154.6m1.32% 1.32% UnchangedShares held: Q3 2025 4.9m, Q4 2025 4.9m, Q1 2026 4.9m, Q2 2026 4.9m
29 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 10,700,974 $151.4m1.29% 1.29% AddedShares held: Q3 2025 8.7m, Q4 2025 8.8m, Q1 2026 10.6m, Q2 2026 10.7m +68.6k +68,584 0.7%
30 IMMATICS N.V SHS IMTX IMTX 12,946,176 $131.1m1.12% 1.12% AddedShares held: Q3 2025 8.8m, Q4 2025 11.4m, Q1 2026 12.9m, Q2 2026 12.9m +76.8k +76,836 0.6%
31 ZAI LAB LTD ADR ZLAB ZLAB 6,574,032 $124.9m1.07% 1.07% UnchangedShares held: Q3 2025 2.3m, Q4 2025 7.0m, Q1 2026 6.6m, Q2 2026 6.6m
32 IMMUNOVANT INC COM IMVT IMVT 3,177,849 $122.4m1.05% 1.05% UnchangedShares held: Q3 2025 0, Q4 2025 3.2m, Q1 2026 3.2m, Q2 2026 3.2m
33 BELITE BIO INC SPONSORED ADS BLTE BLTE 715,332 $110.2m0.94% 0.94% UnchangedShares held: Q3 2025 312.5k, Q4 2025 715.3k, Q1 2026 715.3k, Q2 2026 715.3k
34 XENCOR INC COM XNCR XNCR 6,777,461 $109.1m0.93% 0.93% UnchangedShares held: Q3 2025 6.2m, Q4 2025 6.8m, Q1 2026 6.8m, Q2 2026 6.8m
35 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 13,560,258 $92.3m0.79% 0.79% ReducedShares held: Q3 2025 24.4m, Q4 2025 16.4m, Q1 2026 13.7m, Q2 2026 13.6m -120.0k -119,990 -0.9%
36 COGENT BIOSCIENCES INC COM COGT COGT 2,309,021 $89.4m0.76% 0.76% ReducedShares held: Q3 2025 3.5m, Q4 2025 7.6m, Q1 2026 5.5m, Q2 2026 2.3m -3.1m -3,149,654 -57.7%
37 ALKERMES PLC SHS ALKS ALKS 1,672,356 $87.6m0.75% 0.75% UnchangedShares held: Q3 2025 1.7m, Q4 2025 1.7m, Q1 2026 1.7m, Q2 2026 1.7m
38 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 1,607,507 $86.3m0.74% 0.74% NewShares held: Q3 2025 0, Q4 2025 100.0k, Q1 2026 0, Q2 2026 1.6m
39 REPLIMUNE GROUP INC COM REPL REPL 7,411,581 $82.0m0.70% 0.70% AddedShares held: Q3 2025 6.4m, Q4 2025 7.1m, Q1 2026 7.4m, Q2 2026 7.4m +54.7k +54,665 0.7%
40 CASTLE BIOSCIENCES INC COM CSTL CSTL 2,778,335 $66.3m0.57% 0.57% AddedShares held: Q3 2025 0, Q4 2025 2.1m, Q1 2026 2.8m, Q2 2026 2.8m +20.0k +20,000 0.7%
41 CANDEL THERAPEUTICS INC COM CADL CADL 6,422,018 $66.1m0.56% 0.56% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 6.4m, Q2 2026 6.4m
42 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 17,687,772 $60.5m0.52% 0.52% UnchangedShares held: Q3 2025 17.7m, Q4 2025 17.7m, Q1 2026 17.7m, Q2 2026 17.7m
43 KODIAK SCIENCES INC COM KOD KOD 1,487,934 $58.0m0.49% 0.49% UnchangedShares held: Q3 2025 0, Q4 2025 1.5m, Q1 2026 1.5m, Q2 2026 1.5m
44 AKTIS ONCOLOGY INC COM AKTS AKTS 1,592,043 $51.3m0.44% 0.44% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.6m, Q2 2026 1.6m
45 AXOGEN INC COM AXGN AXGN 1,011,576 $46.7m0.40% 0.40% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
46 DANAHER CORPORATION COM DHR DHR 230,000 $43.8m0.37% 0.37% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 230.0k
47 CULLINAN THERAPEUTICS INC COM CGEM CGEM 2,364,347 $43.1m0.37% 0.37% AddedShares held: Q3 2025 1.7m, Q4 2025 1.7m, Q1 2026 1.7m, Q2 2026 2.4m +658.4k +658,387 38.6%
48 NEUROGENE INC COM NGNE NGNE 1,362,456 $42.8m0.37% 0.37% UnchangedShares held: Q3 2025 1.4m, Q4 2025 1.4m, Q1 2026 1.4m, Q2 2026 1.4m
49 HINGE HEALTH INC CL A HNGE HNGE 500,000 $41.5m0.35% 0.35% ReducedShares held: Q3 2025 0, Q4 2025 353.5k, Q1 2026 1.9m, Q2 2026 500.0k -1.4m -1,430,000 -74.1%
50 ORCHESTRA BIOMED HLDGS INC COM OBIO OBIO 9,556,063 $41.2m0.35% 0.35% AddedShares held: Q3 2025 8.3m, Q4 2025 8.3m, Q1 2026 8.3m, Q2 2026 9.6m +1.2m +1,250,000 15.1%
51 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 3,892,926 $38.9m0.33% 0.33% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.9m
52 SAVARA INC COM SVRA SVRA 5,952,380 $36.7m0.31% 0.31% UnchangedShares held: Q3 2025 0, Q4 2025 6.0m, Q1 2026 6.0m, Q2 2026 6.0m
53 AQUESTIVE THERAPEUTICS INC COM AQST AQST 7,426,471 $30.9m0.26% 0.26% UnchangedShares held: Q3 2025 6.2m, Q4 2025 6.2m, Q1 2026 7.4m, Q2 2026 7.4m
54 KYMERA THERAPEUTICS INC COM KYMR KYMR 240,000 $27.5m0.23% 0.23% UnchangedShares held: Q3 2025 0, Q4 2025 240.0k, Q1 2026 240.0k, Q2 2026 240.0k
55 VERASTEM INC COM NEW VSTM VSTM 6,635,793 $25.3m0.22% 0.22% AddedShares held: Q3 2025 5.4m, Q4 2025 6.6m, Q1 2026 6.6m, Q2 2026 6.6m +59.5k +59,487 0.9%
56 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 248,063 $24.2m0.21% 0.21% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 248.1k, Q2 2026 248.1k
57 BETA BIONICS INC COM BBNX BBNX 1,500,000 $23.5m0.20% 0.20% ReducedShares held: Q3 2025 3.3m, Q4 2025 2.5m, Q1 2026 2.0m, Q2 2026 1.5m -500.0k -500,000 -25.0%
58 CENTURY THERAPEUTICS INC COM IPSC IPSC 8,695,652 $21.3m0.18% 0.18% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 8.7m, Q2 2026 8.7m
59 EVOMMUNE INC COM SHS EVMN EVMN 1,502,235 $20.0m0.17% 0.17% UnchangedShares held: Q3 2025 0, Q4 2025 1.3m, Q1 2026 1.5m, Q2 2026 1.5m
60 BEAM THERAPEUTICS INC COM BEAM BEAM 570,394 $19.6m0.17% 0.17% UnchangedShares held: Q3 2025 0, Q4 2025 570.4k, Q1 2026 570.4k, Q2 2026 570.4k
61 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 400,000 $18.8m0.16% 0.16% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 300.0k, Q2 2026 400.0k +100.0k +100,000 33.3%
62 IDEAYA BIOSCIENCES INC COM IDYA IDYA 370,370 $13.8m0.12% 0.12% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 370.4k
63 ATAIBECKLEY INC COM SHS ATAI ATAI 2,000,000 $10.5m0.09% 0.09% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.0m, Q2 2026 2.0m
64 MILESTONE PHARMACEUTICALS IN COM MIST MIST 7,833,336 $10.5m0.09% 0.09% AddedShares held: Q3 2025 2.5m, Q4 2025 2.5m, Q1 2026 6.3m, Q2 2026 7.8m +1.5m +1,502,335 23.7%
65 OCUGEN INC COM OCGN OCGN 6,666,666 $10.2m0.09% 0.09% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 6.7m, Q2 2026 6.7m
66 TENAX THERAPEUTICS INC COM NEW TENX TENX 696,570 $10.1m0.09% 0.09% AddedShares held: Q3 2025 378.3k, Q4 2025 378.3k, Q1 2026 370.2k, Q2 2026 696.6k +326.3k +326,324 88.1%
67 HEARTFLOW INC COM HTFL HTFL 295,000 $8.7m0.07% 0.07% ReducedShares held: Q3 2025 495.0k, Q4 2025 495.0k, Q1 2026 495.0k, Q2 2026 295.0k -200.0k -200,000 -40.4%
68 PERCEPTIVE CAP SOLUTIONS COR CL A ORD SHS FRNM FRNM 742,500 $8.1m0.07% 0.07% UnchangedShares held: Q3 2025 742.5k, Q4 2025 742.5k, Q1 2026 742.5k, Q2 2026 742.5k
69 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 1,350,000 $7.8m0.07% 0.07% UnchangedShares held: Q3 2025 900.0k, Q4 2025 1.4m, Q1 2026 1.4m, Q2 2026 1.4m
70 LARIMAR THERAPEUTICS INC COM LRMR LRMR 2,565,999 $7.8m0.07% 0.07% AddedShares held: Q3 2025 3.1m, Q4 2025 3.1m, Q1 2026 1.5m, Q2 2026 2.6m +1.1m +1,065,999 71.1%
71 LUMEXA IMAGING HOLDINGS INC COM LMRI LMRI 650,000 $7.3m0.06% 0.06% UnchangedShares held: Q3 2025 0, Q4 2025 650.0k, Q1 2026 650.0k, Q2 2026 650.0k
72 ALLOGENE THERAPEUTICS INC COM ALLO ALLO 3,250,000 $6.8m0.06% 0.06% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.2m
73 CRESCENT BIOPHARMA INC. COM CBIO CBIO 372,856 $6.7m0.06% 0.06% UnchangedShares held: Q3 2025 0, Q4 2025 372.9k, Q1 2026 372.9k, Q2 2026 372.9k
74 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 475,737 $6.3m0.05% 0.05% UnchangedShares held: Q3 2025 0, Q4 2025 475.7k, Q1 2026 475.7k, Q2 2026 475.7k
75 MAZE THERAPEUTICS INC COM MAZE MAZE 212,000 $6.3m0.05% 0.05% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 212.0k
76 CAPRICOR THERAPEUTICS INC COM NEW CAPR CAPR 250,000 $6.0m0.05% 0.05% UnchangedShares held: Q3 2025 0, Q4 2025 250.0k, Q1 2026 250.0k, Q2 2026 250.0k
77 KALARIS THERAPEUTICS INC COM KLRS KLRS 1,300,000 $5.3m0.05% 0.05% UnchangedShares held: Q3 2025 0, Q4 2025 1.3m, Q1 2026 1.3m, Q2 2026 1.3m
78 ABIVAX SA SPONSORED ADS ABVX ABVX 26,400 $3.5m0.03% 0.03% NewShares held: Q3 2025 350.0k, Q4 2025 0, Q1 2026 0, Q2 2026 26.4k
79 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 175,000 $3.2m0.03% 0.03% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 857.0k, Q2 2026 175.0k -682.0k -681,962 -79.6%
80 MEDLINE INC COM CL A MDLN MDLN 70,000 $2.8m0.02% 0.02% UnchangedShares held: Q3 2025 0, Q4 2025 70.0k, Q1 2026 70.0k, Q2 2026 70.0k
81 DISC MEDICINE INC COM IRON IRON 30,000 $2.2m0.02% 0.02% UnchangedShares held: Q3 2025 0, Q4 2025 30.0k, Q1 2026 30.0k, Q2 2026 30.0k
82 IMAGENEBIO INC COM IMA IMA 334,445 $2.0m0.02% 0.02% UnchangedShares held: Q3 2025 334.4k, Q4 2025 334.4k, Q1 2026 334.4k, Q2 2026 334.4k
83 EXAGEN INC COM XGN XGN 195,000 $906.8k0.01% 0.01% ReducedShares held: Q3 2025 1.7m, Q4 2025 790.5k, Q1 2026 395.2k, Q2 2026 195.0k -200.2k -200,231 -50.7%
84 ROCKET PHARMACEUTICALS INC *W EXP 09/02/202 *W EXP 09/02/202 350,000 $1.2k0.00% 0.00% UnchangedShares held: Q3 2025 350.0k, Q4 2025 350.0k, Q1 2026 350.0k, Q2 2026 350.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
APOGEE THERAPEUTICS INC 2,782,097 $234.2m2.8m shares
APELLIS PHARMACEUTICALS INC APLS APLS 3,685,045 $148.2m3.7m shares
INTUITIVE SURGICAL INC ISRG ISRG 220,000 $101.4m220.0k shares
CENTESSA PHARMACEUTICALS PLC 2,054,175 $81.6m2.1m shares
CRINETICS PHARMACEUTICALS IN CRNX CRNX 1,451,326 $52.7m1.5m shares
WAYSTAR HLDG CORP WAY WAY 1,630,000 $39.3m1.6m shares
ARROWHEAD PHARMACEUTICALS IN ARWR ARWR 585,682 $36.7m585.7k shares
STRYKER CORPORATION SYK SYK 100,000 $32.9m100.0k shares
COMPASS THERAPEUTICS INC CMPX CMPX 4,186,599 $22.1m4.2m shares
FULGENT GENETICS INC FLGT FLGT 1,289,000 $20.5m1.3m shares
JADE BIOSCIENCES INC JBIO JBIO 573,205 $8.1m573.2k shares
INVENTIVA SA IVA IVA 1,298,702 $7.2m1.3m shares
OMADA HEALTH INC OMDA OMDA 200,000 $2.5m200.0k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 34.

CompanyTickerStakeChange ScheduleLast filed
ALLURION TECHNOLOGIES INC 13D · filed 2026-03-02 39.4% -8.7 pts 13D 2026-03-02
ORCHESTRA BIOMED HLDGS INC OBIO · 13D · filed 2026-04-29 OBIO 19.2%≈ $51.5m -0.5 pts 13D 2026-04-29
ALLURION TECHNOLOGIES INC 13D · filed 2025-02-24 17.6% 13D 2025-02-24
ESTABLISHMENT LABS HLDGS INC ESTA · 13G · filed 2025-02-14 ESTA 10.0%≈ $242.2m 13G 2025-02-14
NEUROGENE INC NGNE · 13G · filed 2025-02-14 NGNE 10.0%≈ $47.1m 13G 2025-02-14
TENAX THERAPEUTICS INC TENX · 13G · filed 2026-08-14 TENX 9.9%≈ $41.7m no change 13G 2026-08-14
MILESTONE PHARMACEUTICALS IN MIST · 13G · filed 2026-05-15 MIST 9.9%≈ $16.6m no change 13G 2026-05-15
STOKE THERAPEUTICS INC STOK · 13G · filed 2026-05-15 STOK 9.9%≈ $194.4m -0.1 pts 13G 2026-05-15
COMPASS PATHWAYS PLC CMPS · 13G · filed 2026-05-15 CMPS 9.9% no change 13G 2026-05-15
VERASTEM INC VSTM · 13G · filed 2026-05-15 VSTM 9.9%≈ $34.5m no change 13G 2026-05-15
CG ONCOLOGY INC CGON · 13G · filed 2026-08-14 CGON 9.7%≈ $605.0m +1.4 pts 13G 2026-08-14
IMMATICS N.V IMTX · 13G · filed 2026-05-15 IMTX 9.6%≈ $130.4m +1.1 pts 13G 2026-05-15
CASTLE BIOSCIENCES INC CSTL · 13G · filed 2026-05-15 CSTL 9.3%≈ $65.8m +2.1 pts 13G 2026-05-15
TANGO THERAPEUTICS INC TNGX · 13G · filed 2026-05-15 TNGX 9.3%≈ $415.8m new 13G 2026-05-15
REPLIMUNE GROUP INC REPL · 13G · filed 2026-05-15 REPL 8.9%≈ $81.4m +0.7 pts 13G 2026-05-15
GH RESEARCH PLC GHRS · 13G · filed 2025-05-15 GHRS 8.9%≈ $147.8m 13G 2025-05-15
RAPT THERAPEUTICS INC 13G · filed 2025-05-15 8.9% new 13G 2025-05-15
CANDEL THERAPEUTICS INC CADL · 13G · filed 2026-05-15 CADL 8.8%≈ $66.1m new 13G 2026-05-15
XENCOR INC XNCR · 13G · filed 2025-11-14 XNCR 8.7%≈ $100.2m new 13G 2025-11-14
KAILERA THERAPEUTICS INC KLRA · 13G · filed 2026-08-14 KLRA 8.3%≈ $237.4m new 13G 2026-08-14
PROTAGONIST THERAPEUTICS INC PTGX · 13G · filed 2026-02-17 PTGX 8.1%≈ $620.1m 13G 2026-02-17
TARSUS PHARMACEUTICALS INC TARS · 13G · filed 2025-08-14 TARS 8.1%≈ $215.5m 13G 2025-08-14
ULTRAGENYX PHARMACEUTICAL IN RARE · 13G · filed 2026-08-14 RARE 7.9%≈ $260.3m new 13G 2026-08-14
CENTURY THERAPEUTICS INC IPSC · 13G · filed 2026-05-15 IPSC 7.1%≈ $32.0m new 13G 2026-05-15
TAYSHA GENE THERAPIES INC TSHA · 13G · filed 2026-05-15 TSHA 7.0%≈ $140.9m -1.3 pts 13G 2026-05-15

Trades reported as a company insider since 1 Apr 2026

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2026-04-27 ORCHESTRA BIOMED HLDGS INC 10% owner · See footnote OBIO Sold 32 $13232 shares -<1%
2026-04-20 KAILERA THERAPEUTICS INC 10% owner · See footnote KLRA Bought 500,000 $8.0m500.0k shares +5%